However, the reason for the observed increased tumorigenic potential of CD44+CD133+ tumor-initiating cells in primary xenografts is largely unknown and a mechanistic explanation for the enhanced tumorigenicity of the CD44+CD133+ subpopulation of primary xenografts remains enigmatic. The gene discussed is CD44; the disease is neoplasm.